{
    "Title": "Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses",
    "URL": "https://doi.org/10.1371/journal.pntd.0004657",
    "Published": "April 29, 2016",
    "Subject_Areas": [
        "T cells",
        "Enzyme-linked immunoassays",
        "Trypanosoma cruzi",
        "Serology",
        "Antibody therapy",
        "Chagas disease",
        "Cytokine therapy",
        "Parasitic diseases"
    ],
    "Authors": {
        "María G. Alvarez": [
            "Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina"
        ],
        "Graciela L. Bertocchi": [
            "Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina"
        ],
        "Gretchen Cooley": [
            "Center for Tropical and Emerging Global Diseases, Athens, Georgia, United States of America"
        ],
        "María C. Albareda": [
            "Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina"
        ],
        "Rodolfo Viotti": [
            "Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina"
        ],
        "Damián E. Perez-Mazliah": [
            "Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina"
        ],
        "Bruno Lococo": [
            "Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina"
        ],
        "Melisa Castro Eiro": [
            "Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina"
        ],
        "Susana A. Laucella": [
            "Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina",
            "Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Buenos Aires, Argentina"
        ],
        "Rick L. Tarleton": [
            "Center for Tropical and Emerging Global Diseases, Athens, Georgia, United States of America"
        ]
    }
}